SCHEMBL7007597

SCHEMBL7007597

CC(C)CC(C(=O)N(C(C)C)C1N=C(c2ccccc2F)c2ccccc2NC1=O)C1(C(N)=O)CC=CC1

nearest known ligand 0.45

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 9/20 0.43
CCKAR P32238 6/20 0.43
TRPV1 Q8NER1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7007057 0.91 CCKBR (0.41) CCKBRCCKARTRPV1
SCHEMBL7006763 0.88 CCKBR (0.39) CCKBRCCKARTRPV1
SCHEMBL7012796 0.80 CCKBR (0.44) CCKBRCCKAR
SCHEMBL7005901 0.80 CCKAR (0.44) CCKBRCCKAR
SCHEMBL7012788 0.77 PSEN1 (0.37) CCKBRCCKAR
SCHEMBL7006359 0.72 CCKBR (0.37) CCKBRCCKAR
SCHEMBL7013368 0.72 CCKBR (0.49) CCKBRCCKAR
SCHEMBL7011891 0.72 CCKBR (0.44) CCKBRCCKAR
SCHEMBL7003908 0.72 CCKBR (0.44) CCKBRCCKARTRPV1
SCHEMBL7008743 0.72 CCKAR (0.44) CCKBRCCKAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1268450-A1 LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF A-BETA PROTEIN PRODUCTION Bristol-Myers Squibb Pharma Company (US) 2003-01-02 EP claimed
WO-2001092235-A1 LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-12-06 WO claimed
EP-1268450-A1 LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF A-BETA PROTEIN PRODUCTION Bristol-Myers Squibb Pharma Company (US) 2003-01-02 EP disclosed
WO-2001092235-A1 LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-12-06 WO disclosed